Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508942 | SCV001715384 | uncertain significance | not provided | 2020-12-02 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294464 | SCV002587647 | uncertain significance | Atypical hemolytic-uremic syndrome | 2021-02-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451778 | SCV004177443 | uncertain significance | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003456238 | SCV004177444 | uncertain significance | Age related macular degeneration 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451780 | SCV004177445 | uncertain significance | Basal laminar drusen | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451779 | SCV004177446 | uncertain significance | Factor H deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005005948 | SCV005630467 | uncertain significance | Basal laminar drusen; Factor H deficiency; Hemolytic uremic syndrome, atypical, susceptibility to, 1; Age related macular degeneration 4 | 2024-02-15 | criteria provided, single submitter | clinical testing |